What Happened?
San Francisco, AK-based Olema-Pharmaceuticals Appointed Sean Bohen as President and Chief Executive Officer
About the Company
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. At Olema we leverage the exquisite knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development.
About the Person
Sean Bohen is President and Chief Executive Officer at Olema Pharmaceuticals. Previously, Sean held various senior HR leadership roles in the industry.
Info Source
News
Short Profile